Series Fund - Developing Growth Portfolio
Summary
Summary
The Fund seeks to deliver long-term growth of capital and income by investing primarily in stocks of large U.S. companies.
Holding | Sector | Assets |
---|
Inspire Medical Systems Inc | Health Care | 2.0% |
Appian Corp | Information Technology | 1.9% |
Shift4 Payments Inc | Information Technology | 1.9% |
Cardlytics Inc | Information Technology | 1.8% |
Natera, Inc. | Health Care | 1.7% |
TG Therapeutics, Inc. | Health Care | 1.7% |
Five9, Inc. | Information Technology | 1.6% |
MKS Instruments, Inc. | Information Technology | 1.5% |
Redfin Corp | Real Estate | 1.5% |
Restoration Hardware Holdings, Inc. | Consumer Discretionary | 1.5% |
Ten largest holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund’s current or future investments. The figures presented are as of the date shown, do not include the Fund’s entire investment portfolio, and may change at any given time.
Holding | Sector | Assets |
---|
Inspire Medical Systems Inc | Health Care | 2.2% |
Appian Corp | Information Technology | 1.9% |
Restoration Hardware Holdings, Inc. | Consumer Discretionary | 1.7% |
Natera, Inc. | Health Care | 1.7% |
Axon Enterprise, Inc. | Industrials | 1.7% |
Cardlytics Inc | Information Technology | 1.7% |
Five9, Inc. | Information Technology | 1.6% |
Paylocity Holding Corp. | Information Technology | 1.6% |
MKS Instruments, Inc. | Information Technology | 1.5% |
Sunrun, Inc. | Industrials | 1.5% |
iRhythm Technologies, Inc. | Health Care | 1.5% |
Insmed, Inc. | Health Care | 1.5% |
Repligen Corp. | Health Care | 1.5% |
LGI Homes, Inc. | Consumer Discretionary | 1.4% |
Evoqua Water Technologies Corp | Industrials | 1.4% |
Shift4 Payments Inc | Information Technology | 1.4% |
National Vision Holdings Inc | Consumer Discretionary | 1.4% |
Semtech Corp. | Information Technology | 1.3% |
Crocs, Inc. | Consumer Discretionary | 1.3% |
Mirati Therapeutics, Inc. | Health Care | 1.3% |
Blueprint Medicines Corp. | Health Care | 1.3% |
Chart Industries, Inc. | Industrials | 1.3% |
Helen of Troy Ltd. | Consumer Discretionary | 1.3% |
Deckers Outdoor Corp. | Consumer Discretionary | 1.3% |
Goosehead Insurance Inc | Financials | 1.3% |
Generac Holdings, Inc. | Industrials | 1.3% |
Enphase Energy, Inc. | Information Technology | 1.3% |
Inphi Corp. | Information Technology | 1.3% |
YETI Holdings Inc | Consumer Discretionary | 1.2% |
Penn National Gaming, Inc. | Consumer Discretionary | 1.2% |
Nevro Corp. | Health Care | 1.2% |
Blackline, Inc. | Information Technology | 1.2% |
Digital Turbine Inc | Information Technology | 1.2% |
Redfin Corp | Real Estate | 1.2% |
Q2 Holdings, Inc. | Information Technology | 1.2% |
Wingstop, Inc. | Consumer Discretionary | 1.2% |
Turning Point Therapeutics Inc | Health Care | 1.2% |
Malibu Boats, Inc. | Consumer Discretionary | 1.2% |
Globant SA | Information Technology | 1.2% |
Bridgebio Pharma Inc | Health Care | 1.2% |
Endava PLC | Information Technology | 1.1% |
Axonics Modulation Technologies Inc | Health Care | 1.1% |
Boston Beer Co., Inc. | Consumer Staples | 1.1% |
Acceleron Pharma, Inc. | Health Care | 1.1% |
SVMK Inc | Information Technology | 1.0% |
Fiverr International Ltd | Consumer Discretionary | 1.0% |
Diodes, Inc. | Information Technology | 1.0% |
Sprout Social Inc | Information Technology | 1.0% |
Freshpet, Inc. | Consumer Staples | 1.0% |
Twist Bioscience Corp | Health Care | 1.0% |
TG Therapeutics, Inc. | Health Care | 1.0% |
Monolithic Power Systems, Inc. | Information Technology | 0.9% |
Invitae Corp | Health Care | 0.9% |
Lumentum Holdings, Inc. | Information Technology | 0.9% |
CRISPR Therapeutics AG | Health Care | 0.9% |
Iovance Biotherapeutics Inc | Health Care | 0.9% |
Penumbra, Inc. | Health Care | 0.8% |
Avalara Inc | Information Technology | 0.8% |
Arena Pharmaceuticals, Inc. | Health Care | 0.8% |
Planet Fitness, Inc. | Consumer Discretionary | 0.8% |
CareDx Inc | Health Care | 0.8% |
Everbridge, Inc. | Information Technology | 0.8% |
CEVA, Inc. | Information Technology | 0.8% |
Littelfuse, Inc. | Information Technology | 0.8% |
Altra Holdings, Inc. | Industrials | 0.7% |
XPO Logistics, Inc. | Industrials | 0.7% |
AZEK Co Inc/The | Industrials | 0.7% |
Adaptive Biotechnologies Corp | Health Care | 0.7% |
Berkeley Lights Inc | Health Care | 0.7% |
Trex Co., Inc. | Industrials | 0.7% |
Guardant Health Inc | Health Care | 0.7% |
Myovant Sciences Ltd | Health Care | 0.7% |
Calix Networks, Inc. | Information Technology | 0.7% |
Stamps.com, Inc. | Consumer Discretionary | 0.7% |
Tandem Diabetes Care, Inc. | Health Care | 0.6% |
Balchem Corp. | Materials | 0.6% |
Jamf Holding Corp | Information Technology | 0.6% |
Cerence Inc | Information Technology | 0.6% |
Seres Therapeutics, Inc. | Health Care | 0.6% |
ChemoCentryx Inc | Health Care | 0.6% |
Flying Eagle Acquisition Corp | Undefined | 0.6% |
Brooks Automation Inc | Information Technology | 0.6% |
Federal Signal Corp. | Industrials | 0.6% |
Schrodinger Inc/United States | Health Care | 0.5% |
Pacific Biosciences of California, Inc. | Health Care | 0.5% |
LiveRamp Holdings Inc | Information Technology | 0.5% |
Trupanion Inc | Financials | 0.5% |
Rocket Pharmaceuticals Inc | Health Care | 0.5% |
Inari Medical Inc | Health Care | 0.5% |
Grocery Outlet Holding Corp | Consumer Staples | 0.5% |
Shockwave Medical Inc | Health Care | 0.5% |
Upwork Inc | Industrials | 0.5% |
Deciphera Pharmaceuticals Inc | Health Care | 0.5% |
Karuna Therapeutics Inc | Health Care | 0.5% |
Western Alliance Bancorp | Financials | 0.5% |
Constellation Pharmaceuticals Inc | Health Care | 0.4% |
Rapid7, Inc. | Information Technology | 0.4% |
Yext Inc | Information Technology | 0.4% |
Datto Holding Corp | Information Technology | 0.3% |
Lemonade Inc | Financials | 0.3% |
Relay Therapeutics Inc | Health Care | 0.3% |
Silk Road Medical Inc | Health Care | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
YOUR REPRESENTATIVE
To contact your representative, enter your zip code and select your channel below.
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
||||
Statutory Prospectus
Publish Date:11/03/2015
|
||||
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
||||
Annual Report
Publish Date:11/03/2015
|
||||
Semi-Annual Report
Publish Date:11/03/2015
|
||||
Fact Sheet
Publish Date:11/03/2015
|
Other Important Information
Portfolio shares of the Lord Abbett Series Funds are not offered directly to the public. These shares are currently offered only to separate accounts of certain insurance companies that are unaffiliated with Lord Abbett.
The Fund's portfolio is actively managed and is subject to change. Holdings are for informational purposes only and are not a recommendation to buy, sell, or hold any security.
The investment return and principal value of an investment in the Fund will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than their original cost. To obtain performance data current to the most recent quarter-end, go to quarter ending performance on our Website or call Lord Abbett at (888) 522-2388.
Investors should carefully consider the investment objectives, risks charges and expenses of the Lord Abbett Funds. This and other important information is contained in the fund's summary prospectus and/or prospectus. To obtain a prospectus or summary prospectus on any Lord Abbett mutual fund, you can click here, contact your investment professional or Lord Abbett Distributor LLC at (888) 522-2388. Read the prospectus carefully before you invest or send money.